Status:
RECRUITING
Improving Recovery After Critical Illness
Lead Sponsor:
Frisius Medisch Centrum
Collaborating Sponsors:
University of Groningen
University Medical Center Groningen
Conditions:
Post Intensive Care Unit Syndrome
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Survival rates of patients with critical illness have increased due to improved facilities and treatment methods in the intensive care unit (ICU). However, surviving critical illness does n...
Detailed Description
Survival rates of critical illness have increased due to improved facilities and treatment methods in intensive care units. However, surviving critical illness does not automatically mean these patien...
Eligibility Criteria
Inclusion
- Inclusion criteria Long stay post-ICU patients (length of stay ≥48h) between 6 weeks and 6 months after hospital discharge AND \>18 years old AND able to visit the hospital 2 times a week AND a RAND-36 physical functioning subscale score \< 67%
- Exclusion criteria
- Allergy to components of ProSource® (Allergy information: gluten-free, lactose-free, NOT cow's milk free (wey-protein), produced in a factory in which soy, wheat and nuts are processed.
- Inability to understand the Dutch language
- Actively participating in a professional physical rehabilitation program during the study period.
- Note: previous participation in a concluded rehabilitation program is NOT an exclusion criterion.
Exclusion
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05182086
Start Date
September 1 2021
End Date
March 1 2025
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Centre Leeuwarden
Leeuwarden, Netherlands, 8934AD